ad35-env
Vaccineexperimental
Clinical trial activity
1 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2010 (NCT01215149)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ad35-env
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01215149 | Phase 1 | Oct 1, 2010 | Aurum Institute, Desmond Tutu HIV Foundation, Harvard University, HIV Vaccine Trials Network, International AIDS Vaccine Initiative, Kenya AIDS Vaccine Initiative, National Institute of Allergy and Infectious Diseases (NIAID), Ragon Institute of MGH, MIT and Harvard |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aurum Institute | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Desmond Tutu HIV Foundation | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2010 |
| HIV Vaccine Trials Network | Academic/Hospital | 1 | 0 | 1 | 2010 |
| International AIDS Vaccine Initiative | Academic/Hospital | 1 | 1 | 1 | 2010 |
| Kenya AIDS Vaccine Initiative | Academic/Hospital | 1 | 0 | 1 | 2010 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 0 | 1 | 2010 |
| Ragon Institute of MGH, MIT and Harvard | Academic/Hospital | 1 | 0 | 1 | 2010 |
8 organizations
Page 1 / 1